Назалонг

Quick links to important sections

Назалонг

Selected form

Method of action: Decongestant, Vasoconstrictive

Treatment option: Edema, Rhinitis

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Назалонг

Quick Facts

Property Description
Active ingredient Oxymetazoline Hydrochloride
Form Nasal Spray / Nasal Drops
Pharmacological class Nasal Decongestant / Alpha-Adrenergic Agonist
Common use Relief from Nasal Congestion (Stuffiness)
Origin Synthetic (Imidazoline Derivative)

What is the Classification and Core Identity of Назалонг?

Назалонг is an Over-The-Counter (OTC) pharmaceutical preparation known for relieving temporary nasal stuffiness, particularly in adults and older children. Its core identity is defined by its single active ingredient, Oxymetazoline Hydrochloride, a synthetic compound belonging to the pharmacological group of sympathomimetic agents.

This medication functions as a topical nasal decongestant, placing it within the category of imidazoline derivatives. The distinct formulation focuses on an aqueous solution suitable for intranasal delivery, providing focused relief. The active substance, Oxymetazoline, is chemically recognized as an alpha-adrenergic agonist, a key feature studied in pharmacological research.

What is the General Benefit and Purpose of Назалонг?

The general purpose of Назалонг is to provide effective relief from the symptoms of nasal congestion and the associated feeling of sinus pressure often accompanying a cold or allergic reaction. The mechanism relies on its powerful action as a vasoconstrictor.

By causing the small blood vessels in the nasal lining to narrow, Oxymetazoline effectively shrinks the swollen membranes. This clinically recognized action confirms that the drug reduces excessive blood flow and fluid within the tissues. This localized reduction in swelling opens the blocked air passages, allowing for easier breathing. The product is typically presented as a metered nasal spray or in the form of nasal drops for direct, targeted application.

What side effects are possible with Назалонг?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of Oxymetazoline, the active ingredient in Назалонг, as classified in regulatory documents.

Adverse Reactions by System-Organ Class

The most commonly reported undesirable effects are localized and temporary, affecting the nasal passage. These are classified as Common and include localized sensations of burning, stinging, and dryness inside the nose, as well as sneezing and increased nasal discharge [DailyMed Label; MedlinePlus].

Less frequent effects are typically Very Rare and involve systemic absorption, potentially affecting other systems. These include reactions classified under Nervous System Disorders (e.g., headache, insomnia, nervousness) and Cardiac/Vascular Disorders (e.g., tachycardia, palpitations, or increased blood pressure) [SmPC-aligned data].

Time-Dependent and Population Safety Constraints

A key safety pattern documented in official labeling relates to the duration of use: Rebound Congestion (Rhinitis medicamentosa) is explicitly linked to the frequent or prolonged use of the nasal spray, which can cause the initial stuffiness to worsen [DailyMed Label].

The regulatory safety profile requires specific caution for several populations due to the drug's sympathomimetic action. Caution is necessary for individuals with pre-existing conditions such as hypertension (high blood pressure), coronary artery disease, diabetes mellitus, and hyperthyroidism [Rwanda FDA SmPC].

Furthermore, official documents note that the most serious adverse reactions, including coma and respiratory depression, have been documented following the accidental oral ingestion of the medication in young children [AAP Publications/FDA Document]. Use is formally contraindicated in cases of known hypersensitivity to any component of the medication.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Oxymetazoline overdose is based on the risk of severe systemic effects resulting from excessive nasal application or accidental oral ingestion.

Documented Overdose Manifestations

Overdose may present with systemic symptoms affecting the central nervous system and the cardiovascular system. Manifestations include lethargy, somnolence, sedation, trembling, and headache. Cardiovascular signs are documented as fluctuations in heart rate, such as bradycardia (decreased rate) or tachycardia (increased rate), and elevated blood pressure (hypertension).


Severe Outcomes and Critical Risk

Authorities classify severe overdose as potentially life-threatening. Documented outcomes include profound CNS depression, leading to stupor and coma, as well as severe respiratory depression. A critical risk is noted for children 5 years of age and younger, where accidental oral ingestion of even a small amount can cause serious harm.


Required Emergency Actions

The official instruction for managing overdose is to seek emergency medical attention immediately. This action is specifically mandated if the medication is swallowed or if any severe symptoms develop. Management is generally symptomatic and supportive treatment, requiring close monitoring of vital signs and contact with the Poison Control Center.

Therapeutic Uses of Назалонг

The use of Назалонг (Oxymetazoline) is centered on providing temporary symptomatic support from pronounced nasal congestion across several common conditions. It is applied in contexts where a blocked nose interferes with daily functioning and comfort. The medication is commonly used to help with these manifestations.

The primary therapeutic support generally offered is to help ease the overall symptom burden during the most challenging phase of the illness. It is relevant for managing symptom clusters that may become disruptive, such as those associated with the common cold, acute upper respiratory infections, allergic rhinitis (hay fever), and congestion linked to sinus pressure.

Property Description
Quick Fact Addresses Nasal Congestion Symptoms

The medication assists with maintaining comfort during symptomatic periods and supports general well-being when these symptoms become heightened. “It is relevant for easing symptoms related to inflammatory or irritative states that create obstruction.”

Symptomatic Support Focus

This medication is commonly used when short-term symptomatic assistance is needed, particularly when a patient experiences pronounced nasal obstruction and impaired airflow. It contributes to easing the overall symptom load by providing focused, temporary assistance.

Regulatory References

  1. DailyMed Label Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Назалонг (Oxymetazoline Hydrochloride)

Official regulatory documents strictly define the patient populations eligible for this medicine based on age, physiological state, and pre-existing medical conditions.

Contraindications and Absolute Restrictions

Use of Oxymetazoline is absolutely contraindicated for individuals with a known allergy or hypersensitivity to the active ingredient or any other component of the product. This constitutes an absolute prohibition of use.

Age-Related Eligibility

The medicine is generally permitted for adults and children 12 years of age and older. Use in children aged 6 to under 12 is restricted and requires adult supervision. The medicine is not established or recommended for general use in children under 6 years of age; administration in this group requires a doctor's advice.

Comorbidity and Conditional Use Restrictions

Regulatory labeling requires that individuals with specific chronic health conditions must consult a doctor before use. These conditions include: heart disease, high blood pressure (hypertension), thyroid disease, diabetes, and difficulty urinating due to an enlarged prostate gland. Furthermore, use during pregnancy or while breastfeeding is also subject to this restriction and requires prior professional consultation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Documented Pharmacodynamic Interactions

The interaction profile for Oxymetazoline Hydrochloride (Назалонг) is established by pharmacodynamic effects that influence blood pressure, stemming from its activity as an alpha-adrenergic agonist. Regulatory documentation defines combinations with certain medicinal product classes that are not recommended due to the potential for severe cardiovascular events, specifically hypertension or hypertensive crisis.

Interacting Classes (Use Not Recommended):

  • Monoamine Oxidase Inhibitors (MAOIs): Co-administration is advised against due to the risk of potentiating vasopressor effects, which may result in severe hypertension.
  • Tricyclic Antidepressants (TCAs): Use is not recommended as it may cause hypertension by enhancing the medication's inherent pressor activity.
  • Nonselective Beta-Adrenergic Antagonists: Combining is not recommended due to the documented risk of hypertension.

Other Documented Constraints

Use with Other Sympathomimetic Agents (Adrenergic Agonists) may lead to additive cardiovascular effects, including further increases in blood pressure. The medication is also documented to slow the rate of absorption of concomitantly administered Intranasal Products. Consistent with the topical route of administration, official labels do not specify clinically significant interactions related to the inhibition or induction of cytochrome P450 metabolic enzymes or drug transporter systems that would alter systemic exposure of co-administered drugs. Furthermore, the regulatory information notes that it is unknown if drinking alcohol affects the product.

Mechanism of Action

How Назалонг Works

The mechanism of action for the molecule in Назалонг is a direct, localized pharmacological effect entirely focused on the vascular system of the nasal mucosa.


Targeted Alpha-Adrenergic Receptor Agonism

The drug acts as a direct agonist on both the Alpha-1 (alpha1) and Alpha-2 (alpha2) Adrenergic Receptors, which are receptors for norepinephrine found primarily on vascular smooth muscle. This activation is the essential molecular step that mimics the sympathetic nervous system's signal to induce vascular smooth muscle contraction.


Mechanistic Cascade: From Molecular Signal to Vasoconstriction

The agonism triggers an intracellular chemical cascade (Gq pathway) that elevates intracellular calcium (Ca^2+) levels within the smooth muscle cells. This calcium signal forces the sustained contraction of the arterioles and venous sinusoids, resulting in localized vasoconstriction.


Resulting Physiological Effect: Tissue Volume Decrease

By constricting these nasal blood vessels, the mechanism limits the volume of blood within the nasal tissues, which influences fluid dynamics across the vascular wall. This localized reduction in blood volume causes a decrease in the volume of the nasal membranes (tissue detrurgence).


Mechanistic Constraints and Limitations

Continuous, high-level stimulation of these receptors can lead to their functional desensitization (tachyphylaxis), weakening the vasoconstrictive response over time. Furthermore, chronic use can lead to a localized ischemia that causes a severe compensatory dilation (functional vasoparalysis) upon drug cessation.

Dosage and Administration Information

Proper Administration of Nasal Decongestants

Назалонг is a nasal decongestant containing oxymetazoline, intended for temporary relief of nasal congestion. To ensure optimal effect and minimize potential side effects, it is crucial to follow proper usage instructions and dosage guidelines.

General Administration Steps

  1. Preparation: Gently blow your nose to clear the nasal passages before application.
  2. Priming (if necessary): If the spray has not been used for an extended period (check product-specific instructions), prime the pump by actuating it into the air until a fine mist appears. Do not prime or test single-use dispensers.
  3. Application: Hold your head in an upright position. Insert the nozzle tip just inside one nostril, aiming the spray away from the center dividing wall (septum) of the nose. Keep the opposite nostril closed.
  4. Dosing: Squeeze the bottle quickly and firmly while breathing in gently through the nostril. Release the pressure on the bottle after the spray is administered.
  5. Completion: Repeat the process in the other nostril, if directed. Do not blow your nose immediately after use. Wipe the nozzle clean with a tissue and replace the cap.

Key Usage Precautions

Guideline Instruction
Duration of Use Do not use this product for more than 3 consecutive days. Prolonged use of oxymetazoline may cause "rebound congestion" (rhinitis medicamentosa), where nasal congestion returns or worsens after the medication wears off.
Dosing Frequency Follow the prescribed or labeled dosage exactly. Generally, the spray is used every 10 to 12 hours as needed, not to exceed two doses in any 24-hour period.
Hygiene Do not share the nasal spray dispenser with others to avoid the spread of infection.

Consult a healthcare professional if your symptoms do not improve after three days of treatment, or if they worsen.

Recent Clinical Evidence

The medication Назалонг (Oxymetazoline) has been studied to assess its effect on the physical discomfort of nasal congestion. The available evidence details the types of research conducted, the outcomes measured, and where scientific understanding remains limited.


Evidence for Use in Acute Nasal Congestion (Common Cold, Acute Rhinitis)

The most established research involves short-term studies used in exploring how symptoms change over time in conditions such as the common cold or acute rhinitis. Research examining short-term symptom changes often relies on Randomized Controlled Trials (RCTs). Studies utilize patient-reported scales to track outcomes related to physical discomfort and employ objective methods, like rhinomanometry, to measure nasal airflow and resistance. Studies exploring short-term symptom changes reported measurements of change in nasal congestion symptoms that were monitored over defined time intervals. These findings describe patterns observed in the studies related to outcomes describing episodic or acute changes. The research base primarily examines short-term use, and long-term effects are not fully established.


Evidence for Congestion Associated with Allergic Rhinitis

Research has been studied for the use of this medication in managing congestion when it is associated with allergic rhinitis. Studies focus on patients diagnosed with allergies and frequently examine the medication as an adjunct (an add-on) to other standard treatments, such as intranasal corticosteroids. Outcomes monitored include changes in patient-reported scores of nasal congestion and assessments of outcomes reflecting daily functioning or activity level. Findings indicate patterns related to a change in patient-reported congestion scores, particularly when the medication was observed in some studies in combination with nasal steroids. The evidence for this indication is often limited due to the variable inclusion of combination treatments, and follow-up durations were restricted.


Long-Term Studies and Follow-Up Observation

While the medication is relevant in trials assessing short-term symptoms, research has explored the consequences of use for longer than typically recommended. These studies detail the observations regarding potential limitations. Research examined scenarios involving more extended administration to explore patterns of systemic or functional imbalance potentially associated with long-term use. Findings describe patterns observed in the studies where outcomes related to physical discomfort were monitored after extended use. Due to these observations, there is limited information for long-term outcomes.


What Remains Unstudied or Uncertain About Назалонг

A primary limitation is the limited information for long-term outcomes, particularly concerning the physical changes in the nasal mucosal lining after using the spray continuously. Comparative evidence is lacking regarding many other available treatments, and evidence quality varies across studies due to differing design approaches. Research provides context but not individual predictions.

Key Studies & References

  1. Label: Afrin Original- oxymetazoline hydrochloride spray (US FDA / DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Назалонг (FAQ)


Q: How quickly does Назалонг usually start working?

Official product information and clinical data indicate that the effects of the medication typically begin quite rapidly, often providing relief from nasal congestion within minutes after it is applied.


Q: Is there a difference in how long Назалонг can be used compared to regular decongestants?

Regulatory guidance advises against using this product for more than 3 consecutive days. This is a specific precaution for this class of decongestant to reduce the risk of rebound congestion (rhinitis medicamentosa), a condition where the stuffiness returns or worsens after the medication wears off.


Q: Can I use Назалонг if I have high blood pressure? (Reason for caution)

Official safety constraints require individuals with high blood pressure (hypertension) to consult a healthcare professional before use. This restriction is necessary because the drug’s mechanism of action—as a sympathomimetic that constricts blood vessels—can potentially lead to an increase in blood pressure or influence other heart-related conditions.


Q: Is there a concern about using Назалонг with certain heart medications?

Regulatory documents advise that combining this product with certain classes of medications, such as Nonselective Beta-Adrenergic Antagonists (which are used for some heart conditions), is not recommended. This combination is advised against due to the potential for severe cardiovascular events, specifically an increase in blood pressure.


Q: Does alcohol interact with the use of Назалонг?

The official regulatory information explicitly states that it is unknown if consuming alcohol affects the product. No specific warnings or advice regarding concurrent use with alcohol are provided in the regulatory labeling.


Q: Is it possible to become dependent on Назалонг?

Official warnings focus on the risk of rebound congestion (rhinitis medicamentosa) with prolonged use. This effect involves congestion recurring or worsening, a pattern sometimes associated with the extended use of decongestants. This reliance on the product to maintain clear breathing is a documented potential limitation.


Q: What happens if I stop using Назалонг suddenly?

If the medication is used frequently or for longer than the recommended short duration, stopping suddenly may trigger rebound congestion (rhinitis medicamentosa). This means the initial nasal stuffiness can return and potentially become worse due to the physical changes in the nasal blood vessels caused by chronic use.


Q: What is the typical duration of effect after one use of Назалонг?

The regulatory-advised dosage regimen specifies that the product is typically used every 10 to 12 hours. This interval is consistent with a duration of effect that may last up to that interval.


Q: Is a nasal drip or bitter taste after using Назалонг considered normal?

Official adverse reaction lists classify increased nasal discharge (nasal drip) as a common temporary side effect. However, a bitter taste is not consistently listed as a common or official side effect in regulatory documents for this product.


Q: What should I do if I accidentally spray too much Назалонг?

If too much is used, particularly if the product is accidentally ingested orally (swallowed), serious adverse reactions are documented, especially in young children. Official safety guidelines specify that in such situations, it may be necessary to seek immediate medical assistance.


Q: Can Назалонг be used for congestion not related to allergies?

Yes. While it is used for congestion related to allergic rhinitis, official labeling and research summaries also document the product's use for the temporary relief of nasal stuffiness associated with the common cold and acute rhinitis.


Q: How does Назалонг affect the lining of the nose?

The drug's primary action is to constrict the blood vessels to reduce swelling in the nose. Common effects directly on the lining include localized sensations of dryness, burning, and stinging. These are listed in official documents as common, temporary adverse reactions.


Q: Can children of all ages use Назалонг?

No. The medicine is generally permitted for adults and children 12 years of age and older. Use in children aged 6 to under 12 is restricted and requires adult supervision, and it is not established or recommended for general use in children under 6 years of age.


Q: Are there any serious side effects associated with Назалонг use?

Official regulatory data classifies some systemic effects as Very Rare, which may affect the heart (e.g., increased blood pressure) or nervous system (e.g., insomnia). The most serious adverse reactions are formally linked to cases of accidental oral ingestion, particularly in young children.


Q: Are there any known interactions between Назалонг and herbal supplements?

While the official label does not list all specific herbal supplements, regulatory-aligned information advises caution with supplements that are known to act as CNS stimulants. This is because using them with the product may lead to additive effects that could increase side effects such as nervousness or palpitations.


Q: Is it normal to feel a mild burning sensation right after using the spray?

Yes. Official side effect listings for the product indicate that localized sensations of burning and stinging inside the nose immediately following application are classified as common temporary adverse reactions.


Q: Can Назалонг be used with other allergy medications, like oral antihistamines?

The official interaction profile primarily focuses on major drug-drug classes like MAOIs and TCAs. While regulatory standards may permit combining an antihistamine with a decongestant, specific interaction guidance for this nasal spray with all oral antihistamines is not uniformly detailed. Patients with concerns about co-administration should refer to the full regulatory label or product insert.


Q: Are there any specific storage requirements for keeping Назалонг effective?

Regulatory labeling dictates that the product must be stored at controlled room temperature (typically 20 C to 25 C). The product information states that it should also be kept in its original container, protected from light and excessive moisture, and not frozen.


Q: Can Назалонг be used to treat sinus infections?

The documented purpose of the drug is the relief of nasal congestion and stuffiness and its associated feeling of sinus pressure. The product is a decongestant, and the regulatory labeling does not include the treatment of bacterial or viral infections.


Q: Can I use Назалонг if I recently had nose surgery?

The product label does not explicitly address post-operative use. Any use following nose surgery is highly conditional and is typically guided by the instructions of a medical professional.


Q: Is the medication absorbed into the rest of the body, or does it only work locally in the nose?

While the medication is designed to provide a localized action on the nasal blood vessels, the active ingredient can be readily absorbed and enter the systemic circulation (the rest of the body). It has a documented elimination half-life of 5 to 8 hours.


Q: Is it okay to share my container of Назалонг with someone else?

No. Regulatory documents explicitly contain a precaution that the nasal spray dispenser is not for sharing with others. This hygiene precaution is necessary to avoid the spread of infection and contamination.


Q: How is the term 'long-acting' applied to Назалонг?

The product is considered 'long-acting' due to the duration of its effect on nasal congestion. This classification is supported by the regulatory-advised dosage regimen, which specifies use every 10 to 12 hours, a significantly longer interval compared to shorter-acting decongestants.


Q: Can Назалонг worsen certain existing medical conditions?

Yes, due to its sympathomimetic action, the medication has the potential to influence conditions like hypertension, heart disease, diabetes mellitus, and hyperthyroidism. Regulatory documents require specific caution for individuals with these pre-existing conditions.


Q: Are there known cases of allergic reactions to the non-active ingredients in Назалонг?

Official contraindications state that the product is absolutely prohibited for use if there is a known hypersensitivity or allergy to any component of the product. This includes a documented intolerance to the active ingredient or any of the non-active substances used in the formulation.


Q: Does the time of day I use Назалонг matter?

Official dosing instructions specify using the product every 10 to 12 hours as needed. Regulatory guidance focuses on the interval between doses and the maximum daily frequency, but it does not mandate a specific time of day (e.g., morning or evening) for administration.


Q: Why do official documents specify certain limitations on who can use this drug?

Limitations are specified by regulators because the drug’s mechanism as a sympathomimetic agent can influence body systems beyond the nose. The restrictions aim to manage the risk of systemic adverse effects (such as increased heart rate or blood pressure) in sensitive populations and to prevent localized issues like rebound congestion from overuse.


Q: Does Назалонг help with facial pressure or pain?

The general purpose of the product is to provide relief from nasal congestion and the associated feeling of sinus pressure. It works by shrinking swollen nasal membranes to open blocked air passages, which can help alleviate the discomfort of pressure.


Q: Is there research on the long-term effects of using Назалонг?

Official documents indicate that the research base primarily examines short-term use and that long-term outcomes are not fully established, reflecting limited information on the consequences of continuous, extended use.

How should Назалонг be stored and disposed of?

Official Storage and Disposal Requirements

Regulatory labeling dictates specific conditions for storing and disposing of this medication to maintain its stability and prevent accidental exposure.

Requirement Type Official Condition
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze.
Environmental Protection Keep in the original, tightly closed container and protect from both light and excessive moisture.
Child Safety The medication must be kept strictly out of the sight and reach of children.
Disposal Do not flush unused or expired product down the sink or toilet. Dispose of the medication according to local government regulations or through a formal community drug take-back program.

All unused product must be discarded after the expiration date or any specified in-use period, as defined on the official packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Назалонг found in:

A-Z Index: